Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |